TP53 and cancer: Both diseases are characterized by metabolic reprogramming (e.g., the Warburg effect in cancer, metabolic inflexibility in HF), dysregulated cell death (apoptosis, ferroptosis), and altered signaling pathways (e.g., p53, Akt/mTOR) [202,203].